Sanofi and Har­ris Poll glob­al he­mo­phil­ia study finds ‘trou­bling dis­con­nect’ be­tween pa­tients and providers

Sanofi wants to open up con­ver­sa­tions about he­mo­phil­ia, es­pe­cial­ly be­tween peo­ple liv­ing with the con­di­tion and their doc­tors.

Dri­ving its am­bi­tion are in­sights from a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER